WOLF 📈 Grey Wolf Animal Health - Overview
Exchange: V • Country: Canada • Currency: CAD • Type: Common Stock •
WOLF: Pharmaceuticals, Nutraceuticals, Consumables, Wound Care, Disposables
Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. It operates through two segments, the Animal Health Business Unit, and the Pharmacy Business Unit. The company engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics. It provides pharmaceuticals, which includes sedaject, ataject, and thyro-tabs canine drugs; and wound care products, including medical tubes, viscose net dressings, elastic bandages, and silicone perforated tapes, as well as medical pet shirt protective wear that comprise pet shirt, pets boot, head cover, and leg sleeves. The company also offers disposables comprising syringes, needles, and IV catheters; and nutraceuticals, which includes Composure Pro, Vertiflex, hide and treat, L-Lysine Pro, Renal Essentials Pro, and Hepaticlear Pro, as well as Entero Aid +Gi and Fibre Boost +Gi health products. Grey Wolf Animal Health Corp. is headquartered in Toronto, Canada. Web URL: https://greywolfah.com
Additional Sources for WOLF Stock
WOLF Stock Overview
| Market Cap in USD | 25m |
| Sector | Consumer Cyclical |
| Industry | Personal Services |
| GiC Sub-Industry | Specialized Consumer Services |
| IPO / Inception |
WOLF Stock Ratings
| Growth 5y | 26.4% |
| Fundamental | 46.7% |
| Dividend | - |
| Rel. Strength Industry | 109 |
| Analysts | - |
| Fair Price Momentum | 1.08 CAD |
| Fair Price DCF | 1.46 CAD |
WOLF Dividends
No Dividends PaidWOLF Growth Ratios
| Growth Correlation 3m | 81.9% |
| Growth Correlation 12m | 19.4% |
| Growth Correlation 5y | 12.6% |
| CAGR 5y | 11.26% |
| CAGR/Mean DD 5y | 0.49 |
| Sharpe Ratio 12m | 0.90 |
| Alpha | 27.85 |
| Beta | 0.99 |
| Volatility | 99.22% |
| Current Volume | 0k |
| Average Volume 20d | 14.7k |
What is the price of WOLF stocks?
As of December 28, 2024, the stock is trading at CAD 1.15 with a total of 0 shares traded.
Over the past week, the price has changed by +2.68%, over one month by +21.05%, over three months by +35.29% and over the past year by +64.29%.
As of December 28, 2024, the stock is trading at CAD 1.15 with a total of 0 shares traded.
Over the past week, the price has changed by +2.68%, over one month by +21.05%, over three months by +35.29% and over the past year by +64.29%.
Is Grey Wolf Animal Health a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Grey Wolf Animal Health (V:WOLF) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 46.72 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WOLF as of December 2024 is 1.08. This means that WOLF is currently overvalued and has a potential downside of -6.09%.
Partly, yes. Based on ValueRay Fundamental Analyses, Grey Wolf Animal Health (V:WOLF) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 46.72 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WOLF as of December 2024 is 1.08. This means that WOLF is currently overvalued and has a potential downside of -6.09%.
Is WOLF a buy, sell or hold?
Grey Wolf Animal Health has no consensus analysts rating.
Grey Wolf Animal Health has no consensus analysts rating.
What are the forecast for WOLF stock price target?
According to ValueRays Forecast Model, WOLF Grey Wolf Animal Health will be worth about 1.2 in December 2025. The stock is currently trading at 1.15. This means that the stock has a potential upside of +2.61%.
According to ValueRays Forecast Model, WOLF Grey Wolf Animal Health will be worth about 1.2 in December 2025. The stock is currently trading at 1.15. This means that the stock has a potential upside of +2.61%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 1.2 | 2.6% |